Voor de beste ervaring schakelt u JavaScript in en gebruikt u een moderne browser!
Je gebruikt een niet-ondersteunde browser. Deze site kan er anders uitzien dan je verwacht.
What regulation, incentives, and governance structures can motivate the private sector to fairly price its medicines? LCHL’s Katrina Perehudoff was invited to speak about this issue at a plenary session for the 4th WHO Fair Pricing Forum.

The 4th WHO Fair Pricing Forum, hosted online, brought together all stakeholders to discuss progress towards and persistent challenges to realizing ‘fair’ prices for medicines and medical products. Katrina spoke at the plenary session,  titled “Optimizing pricing policies and strategies by buyers and sellers”, alongside representatives of health providers, national authorities, and industry. Her contribution, based on her research, focused on the need to ensure cooperation among stakeholders and transparency, build enforcement capacity, and engage civil society. Katrina’s intervention is published on the Medicines Law & Policy blog

Dr. S.K. (Katrina) Perehudoff

Faculteit der Rechtsgeleerdheid

Gezondheidsrecht